US President Donald Trump is not shying away from using the epidemic as a tool to cross the voting divide. He wants anti-coronavirus to hit the market before the US presidential election. But Trump’s intentions have been called into question by anti-corruption agencies. According to a report in the Wall Street Journal, the companies are moving toward government approval until the drugs are proven to be safe and effective. Vaccine makers such as Pfizer, Johnson & Johnson, and Mordana plan to issue a joint statement next week.